Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Precipio Inc PRPO

Healthcare
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. It develops and sells diagnostic products, reagents and services that improve the accuracy and efficiency of diagnostics, and lead to fewer misdiagnoses. The Company’s technologies include HemeScreen and IV-Cell. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through... see more

Recent & Breaking News (NDAQ:PRPO)

Precipio Reminds Investors of Conference Call with Management for Corporate Update and Second Quarter Results

GlobeNewswire August 22, 2018

Precipio Announces Second Quarter 2018 Financial Results and Provides Corporate Update

GlobeNewswire August 17, 2018

Precipio Appoints New Board Member to Replace Departing Director

GlobeNewswire August 9, 2018

Precipio Announces 213% Year-over-Year Revenue Growth in Preliminary Q2-2018 Results

GlobeNewswire July 18, 2018

Precipio and Nucleai Partner to Develop Artificial Intelligence-Powered Hemepath Solution

GlobeNewswire June 26, 2018

Precipio Updates Commercial Pipeline for its ICE-COLD PCR™ Liquid Biopsy Technology

GlobeNewswire June 19, 2018

Precipio Inc. Announces Adjournment of Annual Meeting of Shareholders

GlobeNewswire June 15, 2018

Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018

GlobeNewswire June 14, 2018

Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018

GlobeNewswire June 12, 2018

Precipio Strengthens Patent Portfolio with Expanded Kit Claims for its Liquid Biopsy Enabling DNA Mutation Enrichment Technology

GlobeNewswire June 6, 2018

Precipio Launches Liquid Biopsy DNA Enrichment Sales in Europe with First Order

GlobeNewswire May 24, 2018

Mid-Afternoon Market Update: Dow Down 75 Points; Ardelyx Shares Slide

Benzinga.com  May 22, 2018

Mid-Day Market Update: Dycom Industries Falls On Q3 Miss; America's Car-Mart Shares Gain

Benzinga.com  May 22, 2018

Mid-Morning Market Update: Markets Mixed; AutoZone Profit Beats Expectations

Benzinga.com  May 22, 2018

Benzinga Pro's 5 Stocks To Watch Today

Benzinga.com  May 22, 2018

Precipio Launches ICE COLD-PCR™ Liquid Biopsy Kit for Pancreatic Cancer

GlobeNewswire May 17, 2018

Mid-Day Market Update: Dow Rises 140 Points; Remark Holdings Shares Plunge

Benzinga.com  May 14, 2018

Benzinga Pro's 5 Stocks To Watch Today

Benzinga.com  May 14, 2018

Precipio Announces Preliminary Q1 2018 Year-over-Year Revenue Increase of 286%

GlobeNewswire May 14, 2018

Precipio in Strategic Partnership Discussions for Proprietary Cytogenetics Media IV-Cell

GlobeNewswire April 18, 2018